BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 30155890)

  • 1. The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy-induced gastrointestinal toxicity.
    Secombe KR; Coller JK; Gibson RJ; Wardill HR; Bowen JM
    Int J Cancer; 2019 May; 144(10):2365-2376. PubMed ID: 30155890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbidities.
    Jordan KR; Loman BR; Bailey MT; Pyter LM
    Cancer; 2018 Oct; 124(20):3990-3999. PubMed ID: 29975400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs Regulate Intestinal Immunity and Gut Microbiota for Gastrointestinal Health: A Comprehensive Review.
    Bi K; Zhang X; Chen W; Diao H
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32932716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity.
    Cario E
    Curr Opin Support Palliat Care; 2016 Jun; 10(2):157-64. PubMed ID: 26986508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local and Long-Distance Calling: Conversations between the Gut Microbiota and Intra- and Extra-Gastrointestinal Tract Infections.
    Denny JE; Powell WL; Schmidt NW
    Front Cell Infect Microbiol; 2016; 6():41. PubMed ID: 27148490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive model for risk of severe gastrointestinal toxicity following chemotherapy using patient immune genetics and type of cancer: a pilot study.
    Coller JK; White IA; Logan RM; Tuke J; Richards AM; Mead KR; Karapetis CS; Bowen JM
    Support Care Cancer; 2015 May; 23(5):1233-6. PubMed ID: 25318697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology.
    Frosali S; Pagliari D; Gambassi G; Landolfi R; Pandolfi F; Cianci R
    J Immunol Res; 2015; 2015():489821. PubMed ID: 26090491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut-lung axis: The microbial contributions and clinical implications.
    He Y; Wen Q; Yao F; Xu D; Huang Y; Wang J
    Crit Rev Microbiol; 2017 Feb; 43(1):81-95. PubMed ID: 27781554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between the Gut Microbiome and Systemic Chemotherapy.
    Ervin SM; Ramanan SV; Bhatt AP
    Dig Dis Sci; 2020 Mar; 65(3):874-884. PubMed ID: 32026181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota-Host Interactions in Inborn Errors of Immunity.
    Castagnoli R; Pala F; Bosticardo M; Licari A; Delmonte OM; Villa A; Marseglia GL; Notarangelo LD
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis.
    Man SM
    Nat Rev Gastroenterol Hepatol; 2018 Dec; 15(12):721-737. PubMed ID: 30185915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-zero-sum microbiome immune system interactions.
    Tuganbaev T; Honda K
    Eur J Immunol; 2021 Sep; 51(9):2120-2136. PubMed ID: 34242413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metagenomic cross-talk: the regulatory interplay between immunogenomics and the microbiome.
    Levy M; Thaiss CA; Elinav E
    Genome Med; 2015 Nov; 7():120. PubMed ID: 26589591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining risk of severe gastrointestinal toxicity based on pretreatment gut microbial community in patients receiving cancer treatment: a new predictive strategy in the quest for personalized cancer medicine.
    Wardill HR; Tissing WJE
    Curr Opin Support Palliat Care; 2017 Jun; 11(2):125-132. PubMed ID: 28333867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the gut microbiome in shaping the immune system of chickens.
    Broom LJ; Kogut MH
    Vet Immunol Immunopathol; 2018 Oct; 204():44-51. PubMed ID: 30596380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate production.
    Endesfelder D; Engel M; Davis-Richardson AG; Ardissone AN; Achenbach P; Hummel S; Winkler C; Atkinson M; Schatz D; Triplett E; Ziegler AG; zu Castell W
    Microbiome; 2016 Apr; 4():17. PubMed ID: 27114075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the intestinal microbiome in liver disease.
    Henao-Mejia J; Elinav E; Thaiss CA; Licona-Limon P; Flavell RA
    J Autoimmun; 2013 Oct; 46():66-73. PubMed ID: 24075647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota and host immune responses: a love-hate relationship.
    Tomkovich S; Jobin C
    Immunology; 2016 Jan; 147(1):1-10. PubMed ID: 26439191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breaking down the gut microbiome composition in multiple sclerosis.
    Budhram A; Parvathy S; Kremenchutzky M; Silverman M
    Mult Scler; 2017 Apr; 23(5):628-636. PubMed ID: 27956557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.